Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow
30 mai 2024 08h00 HE
|
Bionano Genomics
Bionano announces a record 39 scientific presentations and posters highlighting optical genome mapping at two upcoming global cytogenetics conferences.
Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet
28 mai 2024 08h00 HE
|
Bionano Genomics
Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet
Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy
21 mai 2024 08h00 HE
|
Bionano Genomics
Optical genome mapping was used in three publications to successfully assess genome integrity in stem cells, CAR-T cells, and iPSCs.
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis
09 mai 2024 08h00 HE
|
Bionano Genomics
Bionano announces significant advancements to its suite of computational tools for comprehensive cancer analysis.
Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress
08 mai 2024 16h01 HE
|
Bionano Genomics
Q1 2024 revenue was $8.8 million, which represents an 18% increase over Q1 2023Total installed base of 347 optical genome mapping (OGM) systems as of Q1 2024, which represents a 34% increase over Q1...
Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024
01 mai 2024 08h00 HE
|
Bionano Genomics
SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 8, 2024, at 4:30 p.m. Eastern...
Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference
30 avr. 2024 16h05 HE
|
Bionano Genomics
SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the RBC...
Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing
24 avr. 2024 08h00 HE
|
Bionano Genomics
Researchers used Cas9-directed Nanopore sequencing to validate structural variants detected by optical genome mapping in leukemia samples.
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence
17 avr. 2024 08h00 HE
|
Bionano Genomics
Bionano and Diagens form strategic partnership to commercialize OGM plus AI cytogenetic analysis for reproductive health in China.
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing
11 avr. 2024 08h00 HE
|
Bionano Genomics
Researchers used optical genome mapping in addition to whole genome sequencing in pediatric leukemia samples and identified additional structural variants.